Home  - Health_Conditions - Myelodysplastic Syndromes

Books Baby Camera Phones Computers Games DVD Electronics Kitchen Magazines Music Garden Software Tools Toys Video Apparel & Accessories Jewelry & Watches Musical Instruments Health & Personal Care Beauty Sports & Outdoors Office Products

e99.com Bookstore

Images

Newsgroups

101-102 of 102    Back | 1  | 2  | 3  | 4  | 5  | 6

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Myelodysplastic Syndromes:     more books (49)

100 Questions & Answers About Myelodysplastic Syndromes by Jason Gotlib, 2007-12-28 21st Century Ultimate Medical Guide to Myelodysplastic Syndromes (Preleukemia, Smoldering Leukemia) - Clinical Information for Physicians and Patients, Treatment Options (Two CD-ROM Set) by PM Medical Health News, 2009-01-28 Medifocus Guidebook on: Myelodysplastic Syndromes by Inc. Medifocus.com, 2010-03-25 Myelodysplastic Syndrome - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References by ICON Health Publications, 2004-04-26 Myelodysplastic Syndromes: Clinical and Biological Advances Myelodysplastic Syndromes: Pathobiology and Clinical Management, Second Edition (Basic and Clinical Oncology) Myelodysplastic Syndromes & Secondary Acute Myelogenus Leukemia: Directions for the New Millennium (Cancer Treatment and Research) The Official Patient's Sourcebook on Myelodysplastic Syndromes: A Revised and Updated Directory for the Internet Age by Icon Health Publications, 2002-11 The Myelodysplastic Syndromes: Pathobiology and Clinical Management (Basic & Clinical Oncology, 27) The Myelodysplastic Syndromes by G. J. Mufti, 1992-08 MyelodysplasticSyndromes (Hematologic Malignancies) by H. J. Deeg, D.T. Bowen, et all 2005-12-05 Myelodysplastic Syndromes: Pathophysiology and Treatment : Proceedings of the Kyoto Symposium on Myelodysplastic Syndromes, Pathophysiology and Treatment, ... August 1987 (International Congress Series) by Kyoto Symposium on Myelodysplastic Syndromes: Pathophysiology and Treatment (1987), Haruto Uchino, et all 1987-12 The Myelodysplastic Syndromes Myelodysplastic Syndromes. Advances in Research and Treatment by Tokyo, Japan) International Symposium on Myelodysplastic Syndromes (1994 : National Cancer Center, 1995-09-01

lists with details

101. Myelodysplastic Syndrome Review! - The Doctors Lounge(TM)
     myelodysplastic syndrome. Hematology. Medical disease review for USMLE, MRCP.A quick summary before the exams.  
     http://www.thedoctorslounge.net/clinlounge/diseases/hematology/myelodysplastic.h
     
     Extractions: Headlines: Myelodysplastic syndrome The myelodysplastic syndromes are a collection of haematological conditions including: All the conditions show abnormalities in the production of one or more of the cellular components of blood (red cells, white cells (other than lymphocytes) and platelets (or their progenitor cells, megakaryocytes). These abnormalities include: neutropenia, anaemia and thrombocytopenia (low cell counts of each) abnormal granules in cells, abnormal nuclear shape and size

102. Myelodysplastic Syndrome And Its Treatment
     The term myelodysplastic syndrome (MDS) is used to describe a condition SUBTYPES OF myelodysplastic SYNDROME (FAB COOPERATIVE GROUP CRITERIA)  
     http://www.centerspan.org/pubs/news/0597c.htm
     
     Extractions: Spring 1997 Volume 4, Number 1 The term myelodysplastic syndrome (MDS) is used to describe a condition characterized by refractory cytopenias in patients whose bone marrows reveal dysplastic changes in at least two of the three hematopoietic cell lines. MDS often undergoes transformation into acute myeloid leukemia (AML), and the leukemias in these patients are generally less responsive to standard induction chemotherapy than those which arise de novo. Therefore, although the morphology of AML is similar regardless of whether the disease develops de novo or after transformation from MDS, the biology of the disease is not. Variations in marrow morphology and differing potentials for survival and transformation to AML among cases of MDS have led to the establishment of a morphologic classification scheme with five subgroups (see table on this page): refractory anemia (RA), refractory anemia with ringed sideroblasts (RARS), refractory anemia with excess blasts (RAEB), RAEB in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMML). RA and RARS patients have fewer than 5% blasts in their bone marrow; RAEB patients have 5-20% blasts, and RAEB-T patients 20-30% blasts. Patients with AML have more than 30% blasts in their bone marrow. MDS can develop de novo (primary MDS) or can arise as a result of prior chemotherapy or chemoradiotherapy for other malignancies or as a result of exposure to a variety of marrow toxins (secondary MDS). Approximately 40-60% of patients with primary MDS have cytogenetic abnormalities at diagnosis, whereas more than 80% of patients with secondary MDS have abnormal karyotypes.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

101-102 of 102    Back | 1  | 2  | 3  | 4  | 5  | 6